Americans are going to get a little healthier.  President Donald Trump this week cut deals with the drug-makers Eli Lilly and Novo Nordisk to increase access to obesity drugs in a major benefit to American public health.  The agreements are a win-win-win — good for consumers , good for the companies and good for Trump.  One of the most irrational superstitions of our time is that Big Pharma, which has for decades been routinely delivering near-miraculous therapeutics to extend and improve our

Tag-uri: Donald Trump